Quantcast

Constitution State News

Thursday, November 21, 2024

FDA Inspection: What type of Connecticut companies were under most scrutiny during January?

Webp ijw6s7vbfr36c32lki2m95inya4m

Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website

Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website

In January, one Biologics company received an FDA inspection in Connecticut, according to the U.S. Food and Drug Administration (FDA).

This represents 33.3% of all inspections conducted in the state in January.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

FDA inspections in Connecticut during January
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products1----
Colors and Cosmetics Technology1----
Compliance: Devices1----
Human Cellular, Tissue, and Gene Therapies1----
Postmarket Assurance: Devices1----

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate

MORE NEWS